CC Small or few human trials. Promising, not proven. How we grade →RCT · 116 adults with type 2 diabetes and dyslipidemia
Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine
Y Zhang, X Li, D Zou, et al. The Journal of Clinical Endocrinology & Metabolism. 2008.
- In plain language
- 1.0 g a day for 3 months lowered fasting glucose, HbA1c, triglycerides and LDL versus placebo; 5 people had constipation.
- Limits
- 3 months; single country; insulin sensitivity not different from placebo.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Berberine dose, side effects and drug interactions: what the trials used and who should skip it
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Berberine and glucose metabolism
- Source
- doi.org/10.1210/jc.2007-2404 · PubMed 18397984
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.